The results indicated that the BF-rTK/GCV treatment significantly increased caspase 8 and caspase 3 in intestinal cancer colo320 xenograft tissues comparing with PBS/GCV group (Figure 7). The gene discussed is CASP8; the disease is intestinal cancer.